Sichuan Qinkang Jianzhijia Pharmaceutical Co., Ltd. announced that it will issue common shares for gross proceeds of CNY 20 million in a round of funding on August 25, 2023. The transaction will include participation from returning investor, Jianzhijia Pharmaceutical Chain Group Co., Ltd. The transaction has been approved at the 24th session of Jianzhijia Pharmaceutical Chain Group Co., Ltd. 5th directorate.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
52.15 CNY | -2.60% | +3.02% | -12.21% |
04-26 | Jianzhijia Pharmaceutical Chain Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
02-13 | JZJ Chain Drugstore Acquires 69 Pharmacies For 46 Million Yuan | MT |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-12.21% | 931M | |
-29.72% | 15.82B | |
-22.51% | 12.65B | |
-22.88% | 6.6B | |
+12.34% | 6.3B | |
-6.01% | 6.11B | |
-1.17% | 4.69B | |
+64.02% | 4.75B | |
-5.50% | 4.02B | |
-8.59% | 3.59B |
- Stock Market
- Equities
- 605266 Stock
- News Jianzhijia Pharmaceutical Chain Group Co., Ltd.
- Sichuan Qinkang Jianzhijia Pharmaceutical Co., Ltd. announced that it expects to receive CNY 20 million in funding from Jianzhijia Pharmaceutical Chain Group Co., Ltd.